← Back to news
Y

Yahoo Finance

Morgan Stanley Sees $190 Billion Upside in Tesla’s Solar Ambitions

Y

How taxes can dim the shine of gold and silver investments

Y

This Artificial Intelligence (AI) Stock Just Beat Earnings Estimates. Is It a Buy?

Y

Can a New CEO Save Workday Stock from the Software Apocalypse?

Y

Bitcoin miner files Chapter 11 after unfortunate fire

Y

A Crypto Collapse Sends Robinhood Stock Back into Oversold Territory. Should You Buy the Dip?

Y

Why Diodes Stock Is Skyrocketing Today

Y

Why Lattice Semiconductor Rallied Today

Y

Saving $500,000 by 40 is a Rare Achievement—How Many Americans Actually Do It?

Y

American Households are Piling Up Debt At Historic Levels

Y

FedEx price target raised by Bank of America on InPost deal

Y

Why the US Jobs Data Makes a Worrying Case for Bitcoin

Y

Unity Software Stock Is Back in Oversold Territory. Is There Any End in Sight for the Bloodshed in U Shares?

Y

Is Northrop Grumman Stock a 2026 Buy After Its 2025 Earnings Beat?

Y

Big Oil embraces global exploration again as Chevron returns to Libya

Y

Bitcoin and XRP Are Crashing. Should You Buy the Dip?

Y

Meta Is Quietly Building a New Moat: Is META Stock A Buy Now?

Y

Dollar Gains as Strong Jobs Report Reduces Fed Rate Cut Chances

Y

Mortgage rates drop to new three-year low

Y

3 Reasons to Buy Netflix Stock Now

Y

Geopolitical Risks Support Crude Oil Prices

Y

Nat-Gas Prices Rebound in Anticipation of a Large Inventory Withdrawal

Y

Rodman & Renshaw Initiates Ascentage Pharma Group International (AAPG) with Buy Rating, $48 Target

Y

Buy Rating Maintained on Lipocine Inc. (LPCN) as Target Climbs to $15

Y

CorMedix Inc. (CRMD) Board Approves Multi-Year $75M Stock Buyback

Y

Clear Street Raises Delcath Systems, Inc. (DCTH) Target to $29, Maintains Buy Rating

Y

RxSight, Inc. (RXST) Initiated at Market Perform as Firm Seeks Sales Reacceleration

Y

Ardelyx, Inc. (ARDX) Reports Strong 2025 Revenue Growth, Updates 2026 Outlook

Y

Goldman Sachs Raises TG Therapeutics, Inc. (TGTX) Target to $39 on 2026 Guidance

Y

Oscar Health, Inc. (OSCR) Upgraded as Valuation Appears Balanced

Y

Barclays Starts Moderna, Inc. (MRNA) Neutral as Biotech Outlook Improves

Y

H.C. Wainwright Raises Protagonist Therapeutics, Inc. (PTGX) Target to $117, Reiterates Buy

Y

Will Tech Stocks Bounce Back or Should You Sell Them Instead?

Y

As Short Sellers Apologize, Should You Snap Up Embattled AppLovin Stock?

Y

This High Dividend ETF Keeps Investors Out of Harm's Way and It's Soaring

Y

3 Important Things Crypto Investors Need to Know About the Senate Banking Committee's Clarity Act

Y

Better Defense Stock: Lockheed Martin vs. Rheinmetall

Y

Amazon.com Stock Declines Again. This Is Its Worst Run Since 2022.

Y

Ackman's hedge fund Pershing Square bets on Meta, exits Hilton

Y

Preparing To Spend $10,000 a Month in Retirement? Here's What That Looks Like

Y

Hilton Slips as Quarterly Results Confront High Bar

Y

MYX Falls Below $5 as Short Sellers Take Control — 42% Decline Risk Emerges

Y

The AI-fueled software meltdown is overblown

Y

Mysterious trader bets millions right after latest BlackRock announcement

Y

Dan Ives Can’t Get Enough of These 2 Software Stocks Despite ‘Armageddon’ Worries

Y

Why Vertiv Stock Is Skyrocketing Today

Y

Bill allowing Uber Technologies, Inc. (UBER) and Lyft in Israel Receives Committee Approval

Y

Why This Friday Could Be a Big Day for the Stock Market

Y

AEye Signs Strategic Partnership with Vueron to Expand its OPTIS™ Perception Ecosystem

Y

Trump-Led Trade Deal Review Poses ‘Important Risk’ to Outlook, Bank of Canada Minutes Say

Y